Immediate Impact

2 by Nobel laureates 3 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Julie Hafner being referenced

ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers
2010
Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Julie Hafner 419 229 132 16 626
Raymond A. Dwek 375 150 57 11 648
Omer Junaidi 251 100 110 10 530
Jonathan Krakover 513 263 54 10 724
Hironobu Fujii 273 242 107 21 539
Piet J. Boender 329 65 83 23 577
Alan A. Waldman 192 172 106 20 538
Thomas Schreitmüller 282 107 116 13 526
Ellen C. Havenaar 352 179 37 11 522
Heinz‐Kurt Hochkeppel 383 182 236 16 662
Eugene Dempsey 315 162 78 24 674

All Works

Loading papers...

Rankless by CCL
2026